Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT06699446
Recruiting Not applicable

The "Seamless" Patient:From Preoperative Preparation to Postoperative Rehabilitation

NCT06699446 · tracked via the Priya Life Science Germany tracker
Sponsor
Hannover Medical School
Phase
Not applicable
Started
2023-06-28
Last updated
2024-11-21

Condition(s) studied

Heart Failure

Investigational drug(s) / intervention(s)

pre rehabilitation

pre rehabilitation: preoperative pre-rehabilitation (respiratory training, exercise therapy). Establish an individualized rehabilitation plan and postoperative communication via telephone or app

Study summary

The "seamless" patient: from preoperative preparation to postoperative rehabilitation.

The effects of digital services for perioperative care of patients undergoing cardiac surgery will be investigated

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient is capable of giving consent; * planned, elective cardiac surgery (coronary bypass surgery and heart valve surgery incl. combination surgery). The planned surgery can be performed with or without a heart-lung machine. * Minimally invasive procedures may also be explicitly included in the study. Exclusion Criteria: * Emergency care; * congenital heart defects; * age less than 18 years; * patient unable to give consent; * patient unable to perform simple physical training; * high-risk surgery with a calculated Euroscore II of more than 8%.

Primary outcome measure(s)

  • Quality of life of patient via questionnaire — 6 month
    via questionnaire

Trial sites (1)

FacilityCityRegionStatus
Medical School Hanover Hanover Lower Saxony Recruiting

More Hannover Medical School trials in Germany

PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G Recruiting
Auditory Intranerve Stimulation Perceptual Study Recruiting
Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis Recruiting
Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis Active, not recruiting
D-SOLVE Cohorts (Cohort A and B) Recruiting

Other trials for the same condition

Aeson TAH System - Post-Market Clinical Follow-up Study Recruiting
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Recruiting
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany Active, not recruiting
European Registry of Transcatheter Repair for Tricuspid Regurgitation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06699446 on ClinicalTrials.gov ↗ ← All trials in Germany